CTVA vs EDIT · P/E 42, rev $16.91B vs rev $32.3M
Corteva Inc (CTVA) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CTVA and EDIT stock pages for the full models.
Not investment advice.